These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 8254525

  • 1. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W.
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of quantal size at frog neuromuscular junctions: possible roles for elevated intracellular calcium and for protein kinase C.
    Van der Kloot W.
    J Neurobiol; 1991 Mar; 22(2):204-14. PubMed ID: 2030343
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction.
    Van der Kloot W.
    J Neurophysiol; 1987 May; 57(5):1536-54. PubMed ID: 3035113
    [Abstract] [Full Text] [Related]

  • 5. The effect of carbachol and alpha-bungarotoxin on the frequency of miniature endplate potentials at the frog neuromuscular junction.
    Bukharaeva E, Ipatova T, Nikolsky EE, Vyskocil F.
    Exp Physiol; 2000 Mar; 85(2):125-31. PubMed ID: 10751508
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.
    Van der Kloot W, Molgó J, Cameron R, Colasante C.
    J Physiol; 2002 Jun 01; 541(Pt 2):385-93. PubMed ID: 12042346
    [Abstract] [Full Text] [Related]

  • 10. Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction.
    Van der Kloot W, Brănişteanu DD.
    Pflugers Arch; 1992 Mar 01; 420(3-4):336-41. PubMed ID: 1375990
    [Abstract] [Full Text] [Related]

  • 11. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.
    Tian L, Prior C, Dempster J, Marshall IG.
    J Physiol; 1994 May 01; 476(3):517-29. PubMed ID: 7914535
    [Abstract] [Full Text] [Related]

  • 12. Cholinergic regulation of the evoked quantal release at frog neuromuscular junction.
    Nikolsky EE, Vyskocil F, Bukharaeva EA, Samigullin D, Magazanik LG.
    J Physiol; 2004 Oct 01; 560(Pt 1):77-88. PubMed ID: 15254150
    [Abstract] [Full Text] [Related]

  • 13. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
    Liang SD, Vizi ES.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):650-5. PubMed ID: 9023275
    [Abstract] [Full Text] [Related]

  • 14. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
    Rao TS, Correa LD, Lloyd GK.
    Neuropharmacology; 1997 Jan 01; 36(1):39-50. PubMed ID: 9144640
    [Abstract] [Full Text] [Related]

  • 15. A chloride channel blocker reduces acetylcholine uptake into synaptic vesicles at the frog neuromuscular junction.
    Van der Kloot W.
    Brain Res; 2003 Jan 31; 961(2):287-9. PubMed ID: 12531496
    [Abstract] [Full Text] [Related]

  • 16. Effects of the ionophore X-537A on acetylcholine release at the frog neuromuscular junction.
    Kita H, Van Der Kloot W.
    J Physiol; 1976 Jul 31; 259(1):177-98. PubMed ID: 182959
    [Abstract] [Full Text] [Related]

  • 17. Cholinergic agonists decrease quantal output at the frog neuromuscular junction by targeting a calcium channel blocked by omega-conotoxin.
    Van der Kloot W, Molgó J, Naves LA.
    Pflugers Arch; 1997 Nov 31; 434(6):735-41. PubMed ID: 9306006
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS, Gill DS.
    Eur J Neurosci; 1996 Mar 31; 8(3):437-45. PubMed ID: 8963434
    [Abstract] [Full Text] [Related]

  • 19. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
    Grinnell AD, Pawson PA.
    J Physiol; 1989 Nov 31; 418():397-410. PubMed ID: 2576068
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic actions of oxotremorine on murine skeletal muscle. Evidence against muscarinic modulation of acetylcholine release.
    Hong SJ, Chang CC.
    Brain Res; 1990 Nov 26; 534(1-2):142-8. PubMed ID: 2073579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.